Sandostatin and Myasthenia gravis - a phase IV clinical study of FDA data

Summary:

Myasthenia gravis is found among people who take Sandostatin, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Sandostatin and have Myasthenia gravis. It is created by eHealthMe based on reports of 42,695 people who have side effects when taking Sandostatin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 17, 2022

42,695 people reported to have side effects when taking Sandostatin.
Among them, 7 people (0.02%) have Myasthenia gravis.


What is Sandostatin?

Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 39,344 Sandostatin users for its effectiveness, alternative drugs and more.

What is Myasthenia gravis?

Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily) is found to be associated with 1,010 drugs and 577 conditions by eHealthMe.

Number of Sandostatin and Myasthenia gravis reports submitted per year:

Could Sandostatin cause Myasthenia gravis?

Gender of people who have Myasthenia gravis when taking Sandostatin *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Myasthenia gravis when taking Sandostatin *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Sandostatin *:

  1. Symbicort: 1 person, 14.29%
  2. Prednisone: 1 person, 14.29%
  3. Cellcept: 1 person, 14.29%

Common side effects people have besides Myasthenia gravis *:

  1. Breathing Difficulty: 3 people, 42.86%
  2. Acute Upper Airway Obstruction (blockage occurs in the upper airway): 2 people, 28.57%
  3. Confusional State: 1 person, 14.29%
  4. Fall: 1 person, 14.29%
  5. Eyelid Ptosis (falling of the upper or lower eyelid): 1 person, 14.29%
  6. Eye Swelling: 1 person, 14.29%
  7. Excoriation (to tear or wear off the skin of): 1 person, 14.29%
  8. Diarrhea: 1 person, 14.29%
  9. Death: 1 person, 14.29%
  10. Cough: 1 person, 14.29%

Common conditions people have *:

  1. Neuroendocrine Tumor: 2 people, 28.57%
  2. Thymoma (a tumour originating from the epithelial cells of the thymus): 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Sandostatin and have Myasthenia gravis?

Check whether Myasthenia gravis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Myasthenia gravis and when was it recovered:

Expand to all the drugs that have ingredients of octreotide acetate:

Alternative drugs to, pros and cons of Sandostatin:

Common Sandostatin side effects:

Browse all side effects of Sandostatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Myasthenia gravis treatments and more:

COVID vaccines that are related to Myasthenia gravis:

Common drugs associated with Myasthenia gravis:

All the drugs that are associated with Myasthenia gravis:

Common conditions associated with Myasthenia gravis:

All the conditions that are associated with Myasthenia gravis:

How the study uses the data?

The study uses data from the FDA. It is based on octreotide acetate (the active ingredients of Sandostatin) and Sandostatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: